Research & Development

Research & Development

We have invested in differentiated pharmaceutical technologies that strengthen our position among established players in the industry.

Our most well-known proprietary transdermal systems include a nitroglycerin patch for the prevention of angina and a fentanyl patch for the management of acute and chronic pain. Both products are manufactured at our facility, exported, and marketed internationally under various brand names.

Building on our extensive expertise in skin science, our R&D team has also developed an epidermal patch for skin acne-prone, which has been marketed by L’Oréal in more than 40 countries.

For more information, please contact: researchdevelopment@lavipharm.com